Evaluation of 8-hydroxy-2′-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation;Analiza stȩżenia 8-hydroksy-2′-deoxyguanozyny w moczu chorych na powierzchownego raka pȩcherza moczowego leczonych zawiesina̧ pra̧tka BCG

Polski Merkuriusz Lekarski

Volumn 19, Issue 112, 2005, Pages 526-528

  Kaczmarek, Piotr ^a,b   Błaszczyk, Jan ^a   Fijałkowski, Paweł ^a   Sierakowska Fijałek, Anna ^a   Niemirowicz, Jerzy ^b   Kasprzak, Andrzej ^b   Baj, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Zakład Fizjologii Człowieka i Biofizyki ^*  (Poland)

Author keywords

8 hydroksy 2 deoxyguanosine; Addukty DNA; BCG therapy; Bladder carcinoma

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BCG VACCINE; ONKO BCG; 8-HYDROXY-2'-DEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OXIDATION; PROGNOSIS; PROTEIN EXPRESSION; RELIABILITY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINE LEVEL; BLADDER TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTROCOAGULATION; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POLAND; TRANSITIONAL CELL CARCINOMA; URINE; UROLOGIC SURGERY;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DEOXYGUANOSINE; ELECTROCOAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 27644583419     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Aksay T., Saygili I., Andican G. i wsp.: Increased formation of 8-hydroxy-2′-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol. Int., 2003, 71(3), 271.
2. Aleman M., Schierloh P., de la Bariera S. i wsp.: Mycobacterium Tuberculosis Triggers Apoptosis in Peripheral Neutrophils Involving Toll-Like Receptor 2 and p38 Mitogen protein Kinase in Tuberculosis Patients. Infection of Immunity, 2004, 5150.
3. Asami S., Manabe J., Tsurudome Y. i wsp.: Cigarette smoking an increase in oxidative DNA damage, 8-hydroxydeoguanosine, in central site of the human lung. Carcinogenesis, 1997, 18(9), 1763.
4. Bartosz G.: Druga twarz tlenu. Wydawnictwo Naukowe PWN, Warszawa 1995.
5. Błaszczyk J., Kȩdziora J., Luciak M. i wsp.: Effect of morphine and naloxone on oxidative metabolism during experimental renal ischemia and reperfusion. Experimental Nephrology, 1994, 2, 364.
6. Chiou Chiuan-Chian, Chang Pi-Yueh, Chan Err-Cheng i wsp.: Urinary 8-hydroksydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostatae cancer. Clinica Chimica Acta, 2003, 334, 87.
7. Degan P., Shigenaga M.K., Park E.M. i wsp.: Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and of 8-hydroxy-2′-deoxyguanosine in DNA by policlonal antibodies. Carcinogenesis, 1991, 12, 5, 865.
8. Emma di C., Formi G., Lollini P.L., Colombo M.P. i wsp.: The intriguing role of polimorphonuclear neutrophis in antitumor reactions. Blood, 2001, 97, 2.
9. Fraga C.G., Onuki J., Lucesoli F. i wsp.: 5-Aminolevulinic acid mediates in the vivo and in vitro Formation of 8-hydroxy-2′-deoxyguanosine in DNA. Carcinogenesis, 1994, 15, 10, 2241.
10. Jackson A.M., Alexandrov A.B., Prescott S. i wsp.: Production of urinary tumour necrosis factor and soluble tumour necrosis factor receptors in bladder cancer patients after bacillus Calmette-Guerin immunotherapy. Cancer Immunol. Immunother., 1955, 40, 119.
11. Kaczmarek P., Błaszczyk J., Kowaski i wsp.: Ocena objawów ubocznych preparatów stosowanych w formie instylacji dopechȩ rzowych u chorych z powierzchownym rakiem pȩcherza moczowego. Polski Merkuriusz Lekarski, 2002, 67, 39.
12. Kaczmarek P., Buczyński A., Niemirowicz i wsp.: Metabolizm tlenowy w krwinkach płytkowych u chorych na raka pȩcherza moczowego leczonych zawiesina̧ pra̧tka BCG. Polski Merkuriusz Lekarski, 2001, 66, 484.
13. Lamm D.L., Thor D.E., Harris S.C. i wsp.: Bacillus Calmette-Guerin immunotherapy of superfitial bladder cancer. J. Urol.,1980, 124, 38 (Medline).
14. Ludwig A.T., Moore J. M., Luo Yi. i wsp.: Tumor Necrosis Faktor - Related Apoptosis - Inducid Ligand. Cancer Research, 64(10), 3386.
15. Min W., Hideki W., Keiichirou M. i wsp.: Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alternations in induced urinary bladder tumors. Carcinogenesis, 2002, 23(8), 1387.
16. Miyake H., Takechi Y., Kamidono S., Hara I.: Increased urinary 8-hydroxy-2′-deoxyguanosine excretion after ileal neobladder replacement. BJU Int., 2003, 91(7), 657.
17. Morales A., Eidinger D., Bruce E.: Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol., 1976, 116, 180 (Medline).
18. Nishibayashi H., Kanayama S., Kiyohara T. i wsp.: Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. Gastroenterol Hepatol., 2003, 18(12), 1384.
19. Oliński R., Jurgowiak M.: Iron metabolizm, oxidative DNA damage and atheosclerosis. Acta Angiol., 2002, 8, 2, 37.
20. Romamnenko A., Morimura K., Wanibuchi H. i wsp.: Inceased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident. Int. J. Cancer, 2000, 86, 790.
21. Seki S., Kitada T., Sakaguchi H. i wsp.: Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology, 2003, 42(4), 365.
22. Tsukahara H., Shibata R., Ohshima Y. i wsp.: Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci., 2003, 72(22), 2509.
23. Yoshimura R., Matsuyama M., Tsuchida K. I.: Expresion of lipoxygenase in human bladder carcinoma a prowth inhibition by its inhibitors. J. Urol., 2003, 170(5), 1994.
24. Zhao W., Schorey J.S., Bong-Mastek M., Ritchey J., Brown E.J., Ratliff T.L.: Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG - induced antitumor activity. Int. J. Cancer, 2000, 86, 83 (Medline).